Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCombined Modality TherapyAntineoplastic AgentsCisplatinCyclophosphamideDoxorubicinTreatment OutcomeNeoadjuvant TherapyDisease-Free SurvivalBreast NeoplasmsEtoposidePrognosisSurvival AnalysisNeoplasm StagingSurvival RateLung NeoplasmsDrug Administration ScheduleMethotrexateCarboplatinPaclitaxelVinblastineInduction ChemotherapyNeoplasm Recurrence, LocalTaxoidsDrug Resistance, NeoplasmIfosfamideNeoplasmsFollow-Up StudiesBleomycinOrganoplatinum CompoundsAntimetabolites, AntineoplasticDeoxycytidineTime FactorsAnthracyclinesCytarabineAntineoplastic Agents, AlkylatingProspective StudiesChemotherapy, Cancer, Regional PerfusionCarcinoma, Non-Small-Cell LungSalvage TherapyAbnormalities, MultipleOvarian NeoplasmsNeoplasm MetastasisChromosome AberrationsTesticular NeoplasmsAdenocarcinomaLymphoma, Non-HodgkinVomitingNeutropeniaTransplantation, AutologousHodgkin DiseaseNauseaAntineoplastic Agents, PhytogenicRadiotherapy, AdjuvantColorectal NeoplasmsRadiotherapyAntibiotics, AntineoplasticClinical Trials as TopicBrain NeoplasmsDacarbazineKaplan-Meier EstimateNeoplasms, Germ Cell and EmbryonalMagnetic Resonance ImagingGranulocyte Colony-Stimulating FactorCarmustineRecurrenceLomustineBone NeoplasmsCamptothecinPlatinum CompoundsTumor Markers, BiologicalDose-Response Relationship, DrugOsteosarcomaDisease ProgressionLeukopeniaMitomycinInfusions, Intra-ArterialMelphalanLiver NeoplasmsHematopoietic Stem Cell TransplantationAntiemeticsInfusions, IntravenousLeukemia, Myeloid, AcuteKaryotypingPrecursor Cell Lymphoblastic Leukemia-LymphomaThiotepaPeritoneal NeoplasmsStomach NeoplasmsMitoxantroneDrug TherapyCell Line, TumorLymphatic MetastasisPalliative CareAntibodies, Monoclonal, HumanizedTegafurCarcinoma, Squamous CellGerminomaRadiotherapy DosageTomography, X-Ray Computed